Dossier · Private startup · 2 independent sources
Rhino Federated Computing
Last updated: Jul 31, 2026
Rhino Federated Computing provides enterprise software for running analytics, machine learning, inference, and controlled code execution across distributed data without moving the underlying records. Its Rhino Federated Computing Platform targets regulated organizations and multi-party collaborations where privacy, intellectual-property protection, security, or data sovereignty constrain centralization.
Visit WebsiteCompany Overview
Rhino Federated Computing sells the Rhino Federated Computing Platform (Rhino FCP), a software layer for coordinating computation across data that remains inside the custodians' cloud or on-premises environments. The platform combines centralized project and policy control with decentralized execution: organizations connect data sources, harmonize schemas, deploy approved workloads in secure containers, and receive permitted outputs rather than exporting raw records. Public product materials describe federated statistics, federated learning, federated inference, model lifecycle management, and support for common machine-learning frameworks. The product is therefore broader than a federated-learning library: its commercial proposition is operational infrastructure for making a difficult multi-party data collaboration governable and repeatable.
The technical value is concentrated in the integration layer. Rhino advertises connectors for cloud and on-premises environments, data discovery and visualization, schema definition, and an AI-assisted AutoMapper/Data Harmonization Engine with human validation. It also describes privacy and security controls including differential privacy, k-anonymization, homomorphic encryption, customer-managed keys, role-based access control, audit logs, and sandboxed code deployment. The presence of these capabilities does not by itself establish that every deployment achieves a particular privacy or compliance guarantee; customers should verify threat models, leakage controls, key-management boundaries, performance overhead, and the scope of any ISO 27001, SOC 2 Type II, HIPAA, or GDPR claims. The newer secure MCP positioning is strategically relevant because it extends governed access to distributed data and models into agentic workflows, but it also creates additional authorization, prompt-injection, monitoring, and model-output risks that require diligence.
Rhino emerged from the healthcare and life-sciences use case, following the EXAM federated-learning work led by co-founder and CEO Ittai Dayan. The company says it began by deploying across academic medical centers and now markets to biopharma, financial services, and other regulated sectors. Its public materials reference more than 60 organizations and programs involving the Cancer AI Alliance, Lilly TuneLab, the FAITE Consortium, and financial-crime or payments-fraud collaborations; these references are useful traction signals, but they do not disclose contract size, recurring revenue, production utilization, or customer concentration. The company announced an oversubscribed $15 million Series A in May 2025 led by AlleyCorp. LinkedIn reports 76 discoverable employees, while the company lists Boston headquarters and a Tel Aviv R&D center. These indicators suggest a funded, commercially active startup, while leaving important questions about revenue quality, implementation effort, renewal rates, and cash runway.
The competitive field includes open-source federated-learning frameworks, hyperscaler and GPU-vendor tooling, clean rooms, confidential-computing systems, and internal platform teams. Rhino's defensibility is consequently more likely to come from deployment know-how, integrations, harmonization, governance workflows, and a growing network of participating sites than from a single proprietary algorithm. Its strongest wedge is a customer that needs several parties to collaborate but cannot obtain approval for a central data lake or an ad hoc research script. The company must still prove that onboarding new nodes becomes faster over time, that federated workloads perform acceptably on heterogeneous infrastructure, and that customers can operate the system without a large bespoke-services burden.
The defense and national-security relevance is credible but indirect. The same local-data execution, policy enforcement, and auditability can support coalition analytics, intelligence or cyber-threat collaboration, cross-agency health surveillance, and critical-infrastructure analysis when organizations cannot pool sensitive data. Public evidence reviewed here does not establish defense contracts, classified deployments, or government adoption, so Rhino should be treated as dual-use infrastructure with an adjacency thesis rather than as a defense supplier. Its strategic importance depends on whether it can meet higher-assurance deployment, identity, supply-chain, offline or disconnected-operation, and data-classification requirements beyond its current commercial references.
Dual-Use Assessment
Rhino's core capability has substantive commercial and security applicability: it coordinates analytics and AI across organizations while keeping sensitive data under local control. Commercial evidence is strongest in healthcare, biopharma, and financial services. A defense or national-security buyer could use the same architecture for coalition intelligence, cyber-threat, critical-infrastructure, or public-health collaboration, but no defense contract or classified deployment was verified, so the defense case remains an adjacency and diligence hypothesis rather than an established revenue stream.
Strategic Fit Assessment
Priority signal means this entry may be worth researching within the Claw & Talon thesis. It does not mean investable, suitable, endorsed, available, or likely to produce returns.
Rhino is a credible strategic-fit signal for a dual-use and deep-tech database because it productizes a persistent bottleneck: organizations want joint AI outcomes but cannot freely centralize regulated, sovereign, or commercially sensitive data. The May 2025 Series A, visible multi-sector programs, and reported 76-person workforce indicate more than a research prototype. The principal diligence questions are whether public collaborations convert into durable recurring revenue, how much deployment depends on services, whether the platform scales across heterogeneous nodes, and whether security and privacy claims withstand independent customer review. This flag is a priority signal, not an investment recommendation.
Strategic Value to U.S.-Israel Alliance
Rhino could become enabling infrastructure for data collaboration in sectors where legal, security, and sovereignty constraints otherwise prevent useful AI. Its strategic value is highest when several independent custodians need a shared model, statistic, or workflow and a central repository is unacceptable. The platform also has potential relevance to national resilience through health, financial-integrity, cyber, and critical-infrastructure use cases. That value is not yet equivalent to defense traction: public evidence reviewed supports a commercial regulated-industry base, while government procurement, classified handling, disconnected operation, and high-assurance identity requirements remain open questions.
Key Technologies
- Federated statistics, learning, inference, and model lifecycle orchestration
- Centralized policy control with decentralized execution across cloud and on-premises nodes
- AI-assisted data harmonization, schema mapping, and multimodal data workflows
- Differential privacy, k-anonymization, homomorphic encryption, and secure aggregation patterns
- Secure containerized code and third-party application deployment at the data source
- Role-based access control, customer-managed keys, audit logging, and privacy-governed data pipelines
- Secure MCP and agentic-AI interfaces for governed cross-institutional data access
Use Cases & Applications
- Multi-hospital model training and inference without centralizing patient-level data
- Biopharma collaboration for drug discovery and biologics-property modeling across proprietary datasets
- Federated clinical research and trusted research environments across academic medical centers
- Cross-bank financial-crime, AML, and payments-fraud analytics under data-residency constraints
- Secure third-party model inference on partner data while protecting both data and model IP
- Cross-agency or coalition analytics for cyber threat, public health, or critical infrastructure
- Governed agentic workflows that query or harmonize distributed enterprise data without unrestricted data access
Sources and verification
This profile is based on public-source research, Claw & Talon curation, and editorial judgment. Inclusion does not imply endorsement, partnership, investment, or a recommendation to transact. Readers should still confirm current status, customers, funding, and product claims before relying on this profile. The editorial policy explains how profiles are researched, where automated drafting is used, and how corrections work; the research methodology documents how evidence is graded, what counts as an independent source, and why some profiles are excluded from search indexing.
This record lists 10 public references used for company identity, status, positioning, or material-claim review.
Public sources
The links below are visible public references used for source discipline around company identity, status, funding, customer, acquisition, public-company, or other material claims where available.
- rhinofcp.com Public source used for profile verification.
- rhinofcp.com Public source used for profile verification.
- rhinofcp.com Public source used for profile verification.
- rhinofcp.com Public source used for profile verification.
- rhinofcp.com Public source used for profile verification.
- rhinofcp.com Public source used for profile verification.
- rhinofcp.com Public source used for profile verification.
- LinkedIn company page Public source used for profile verification.
- investor.lilly.com Public source used for profile verification.
- builtinboston.com Public source used for profile verification.
- Profile update timestamp Last updated in the Claw & Talon database on Jul 31, 2026.
Related sector
See the Cloud & Developer Infrastructure sector page for market context, related subcategories, and other Israeli companies in this part of the database.